NSE filing, NSE: INDIANB. Summary written from the filing by ALFA Finder's alert engine.
Indian Bank: key numbers
- Share price
- ₹839.80
- Market cap
- ₹1,13,118 Cr
- Revenue (annual)
- ₹67,504 Cr
- Net profit (annual)
- ₹11,704 Cr
- P/E (TTM)
- 8.6×Sector 19.7×
- Promoter holding
- 73.84%+0.00% QoQ
- FII holding
- 6.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indian Bank
All →Indian Bank Debt & Borrowing: ₹356 Cr
Indian Bank confirmed payment of Rs.3,56,00,00,000 interest on its Long Term Infrastructure Bonds Series II on 26 October 2026. The bond issue size is Rs.5,000 Crore.
- Value
- ₹356.0 Cr
Indian Bank Management Change
Indian Bank's Government of India nominee director Samir Kumar ceased, and Ms. Manasa Gangotri Kata was nominated as director effective 23 October 2026. The filing confirms no debarment and no relationships with other directors.
Indian Bank Other Announcement
Indian Bank has upwardly revised interest rates for its 'Ind Grow' (555 days) and 'Ind Prosper' (777 days) special retail term deposit schemes.
Indian Bank Legal & Regulatory
RBI inspection observations led to a Rs. 22,079 Crore increase in Indian Bank's Risk Weighted Assets. Capital adequacy ratios remain above regulatory minimums despite the adjustments.
- Value
- ₹22,079 Cr
Indian Bank Investor Presentation: Key Takeaways
Indian Bank reported robust Q2FY27 results with Net Profit increasing 14.71% YoY to ₹3,462 Cr. Growth is driven by RAM segment expansion and improved asset quality.
Indian Bank Results Update
Indian Bank's Q2FY27 net profit was ₹3,462 Cr, up 14.71% YoY, with total business at ₹15.96 lakh Cr. Operating profit rose 46.58% while GNPA fell to 1.61%.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.